Navigation Links
Increase in medical treatment caused greatest increase in US health care costs
Date:5/6/2013

The increasing proportion of the population that received treatment for a specific medical condition called "treated disease prevalence" -- along with higher spending per treated case accounted for most of the rise in health care spending in the U.S. between 1987 and 2009, according to a recent analysis.

In the analysis, published in the May edition of Health Affairs, Kenneth E. Thorpe, PhD, chair of the Department of Health Policy and Management at Emory's Rollins School of Public Health, analyzed data from the National Medical Expenditure Survey and the Medical Expenditure Panel Surveys from 1987-2009 to investigate the roles that the rise in treated disease prevalence, spending per treated case, obesity, and increased treatment intensity played in the increase in health care spending.

The complete report titled, "Treated Disease Prevalence and Spending per Treated Case Drove Most of the Growth in Health Care Spending in 1987-2009," will be part of a discussion at the Health Affairs briefing on Tuesday, May 7, 2013 from 9 a.m. 12:30 p.m. at the National Press Club in Washington, DC.

The paper examined surveys that included detailed information on self-reported medical conditions, monthly markers of health insurance coverage, patients' demographic characteristics, spending, respondent data, medical information, and use of service.

Thorpe determined that 50.8 percent of the rise in health care spending among adults ages 18 years and older was associated with rising rates of treated disease prevalence, while 39.0 percent of that rise was associated with rising spending per treated case.

"In order to determine ways to reduce the rate of growth in health care spending, we must first have a clear understanding of what factors account for the increase," says Thorpe. "Though there have been few attempts to identify these factors, they are important due to the differences from the main drivers of cost growth during previous decades."

According to the examination of studies, Thorpe concluded three major findings that account for the rise in health care spending in the past 20 years:

  • The rising prevalence of treated disease accounted for 50.8 percent of growth in overall spending among adults and 77 percent in the case of Medicare spending. Higher spending per treated case accounted for a 39 percent increase and joint effects of the two accounted for the remaining 10.2 percent.

  • The doubling of obesity since 1987 contributed to 10.4 percent of the overall rise in spending.

  • Increasing treatment intensity accounted for 11.9 percent of the growth spending between 1987-2009.

"The current findings strongly suggest that most of the recent discussion about ways to control increases in spending, particularly among Medicare beneficiaries, may be focused on the wrong set of issues," explains Thorpe.

"What is needed is a broader set of policy options focused on reducing the incidence of disease; and a better understanding of how much of the rise in treated prevalence is the result of a more aggressive treatment of chronic conditions. We also have to look at whether the more intensive treatments yield improvements in morbidity and mortality."


'/>"/>

Contact: Melva Robertson
melva.robertson@emory.edu
404-727-5692
Emory Health Sciences
Source:Eurekalert

Related medicine news :

1. BASPCAN - UK-wide increase in number of children
2. MP3 song-searching can increase risk for drivers
3. Saliva test could dramatically increase detection of oral cancer
4. Regular jogging shows dramatic increase in life expectancy
5. Email vacations decrease stress, increase concentration, researchers say
6. Comorbidities increase risk of mortality in COPD patients
7. Could Eating Fast Increase Diabetes Risk?
8. For Dementia Patients, Feeding Tubes May Increase Bed Sores
9. Reported increase in older adult fall deaths due to improved coding
10. Chemotherapys effect on overall survival seems to increase based on tumor size
11. Dietary supplements increase cancer risk
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/24/2017)... ... March 24, 2017 , ... Empower Brokerage, located ... training and leads programs. , In February, 2017, Empower Brokerage introduced their new ... Partners is designed to teach how to maximize their sales efforts, as well ...
(Date:3/24/2017)... ... March 24, 2017 , ... “End Time GPS”: ... events will interrelate. “End Time GPS” is the creation of published author, Wesley ... while working on military munitions and space-vehicle projects. Now, at age ninety-one, he shares ...
(Date:3/24/2017)... ... ... Adventures of Joey, The Dog Who Barks at Puddles”: a boisterous story about a ... God intended. “The Adventures of Joey, The Dog Who Barks at Puddles” is the ... writing, especially about truth and human behavior. , Published by Christian Faith Publishing, Patti ...
(Date:3/23/2017)... Texas (PRWEB) , ... March 23, 2017 , ... The ... 3rd location in the greater Houston Area. The new location is located at 2255 ... Luke’s Hospital in Springwoods Village. This newest location will provide patients living in the ...
(Date:3/23/2017)... ... March 23, 2017 , ... ... Center at 10 North Broadway Avenue, will be an educational and exciting program ... instruction in the management of chronic pain. , Oklahoma is in a healthcare ...
Breaking Medicine News(10 mins):
(Date:3/24/2017)... Mar. 24, 2017 Research and Markets ... the U.S.: Consumer Strategies" report to their offering. ... Pain ... approach and treat their physical pain, emphasizing consumer survey analysis, ... pain sufferers and adults who have selected illnesses/conditions strongly associated ...
(Date:3/24/2017)... , March 24, 2017 ShangPharma, ... high-quality and cost-effective drug development and discovery ... and biotechnology industry, announced today the intent ... ShangPharma will be consolidating the Contract Research ... under Shanghai ChemPartner. These entities include ChemPartner ...
(Date:3/24/2017)... , Mar. 24, 2017 Research and Markets ... Pipeline Analysis, 2016" report to their offering. ... The IPF pipeline is very strong with a ... Merck & Co., Inc., Biogen and Sanofi are involved in the development ... of which one is in Phase III stage, 15 are in Phase ...
Breaking Medicine Technology: